From: Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study
Variables | Univariate Analysis | Multivariate Analysis | ||
---|---|---|---|---|
 | RR (95% CI) | P | RR (95% CI) | P |
Sex | Â | 0.921 | Â | 0.921 |
 Male | 1 |  | 1 |  |
 Female | 0.96 (0.46–2.04) |  | 0.96 (0.46–2.04) |  |
Age-per 10 years increase | 1.02 (0.76–1.37) | 0.891 | 1.02 (0.76–1.37) | 0.889 |
Transmission route | Â | 0.359 | Â | 0.305 |
 MSM | 1 |  | 1 |  |
 Heterosexual | 1.06 (0.49–2.30) | 0.885 | 1.15 (0.62–2.13) | 0.650 |
 Bisexual | 0.24 (0.03–2.19) | 0.203 | 0.27 (0.03–2.39) | 0.241 |
 Blood | 1.33 (0.10–17.37) | 0.826 | 0.85 (0.08–8.97) | 0.895 |
 Others/Unknown | 0.35 (0.09–1.41) | 0.140 | 0.35 (0.09–1.31) | 0.120 |
Subtype | Â | 0.549 | Â | 0.550 |
 CRF01_AE | 1 |  | 1 |  |
 C/CRF07_BC/CRF08_BC | 1.47 (0.75–2.86) | 0.264 | 1.47 (0.75–2.86) | 0.263 |
 B/B′ | 0.71 (0.23–2.21) | 0.557 | 0.72 (0.23–2.22) | 0.562 |
 Others/Unknown | 1.12 (0.31–4.01) | 0.863 | 1.12 (0.31–4.00) | 0.864 |
Baseline total HIV-1 DNA -per 1 log copies/106 PBMCs | 0.07 (0.03–0.16) | < 0.001 | 0.08 (0.04–0.16) | < 0.001 |
Baseline HIV-1 plasma RNA-per 1 log copies/mL | 1.20 (0.74–1.96) | 0.463 | 1.12 (0.70–1.77) | 0.641 |
Baseline CD4 cell count-per 100 cells/μL | 2.11 (1.28–3.48) | 0.003 | 1.72 (1.35–2.20) | < 0.001 |
Baseline CD8 cell count-per 100 cells/μL | 0.92 (0.81–1.05) | 0.211 | 0.97 (0.90–1.04) | 0.389 |
Baseline CD4/CD8 ratio-per 0.1 increase | 0.87 (0.64–1.19) | 0.391 | 0.86 (0.63–1.17) | 0.340 |